Different effects of cyclic AMP and butyrate on eosinophilic differentiation, apoptosis and bcl-2 expression of a human eosinophilic leukemia cell line, EoL-1

Hematological Oncology

Volumn 14, Issue 4, 1996, Pages 181-192

  Guixiang, Tai ^a   Eun Young, Jung ^a   Yuji, Horiguchi ^a   Masahiko, Kawai ^a   Toshio, Heike ^b   Kenji, Katamura ^a   Kenshi, Furusho ^a   Mitsufumi, Mayumi ^c  

^a KYOTO UNIVERSITY   (Japan)

^b THE UNIVERSITY OF TOKYO   (Japan)

^c UNIVERSITY OF FUKUI   (Japan)

Author keywords

Bcl 2; Butyrate; Cyclic AMP; Differentiation; EoL 1 cells

Indexed keywords

BUCLADESINE; BUTYRIC ACID; CYCLIC AMP; DNA; FAS ANTIGEN; FORSKOLIN; PROSTAGLANDIN E2; PROTEIN BAX; PROTEIN BCL 2;

APOPTOSIS; ARTICLE; CELL CYCLE G1 PHASE; CELL DIFFERENTIATION; CELL GROWTH; CONTROLLED STUDY; EOSINOPHIL; EOSINOPHILIC LEUKEMIA; GRANULE CELL; HUMAN; HUMAN CELL; LEUKEMIA CELL; PRIORITY JOURNAL;

ANTIGENS, CD95; APOPTOSIS; BUCLADESINE; BUTYRIC ACID; BUTYRIC ACIDS; CELL DIFFERENTIATION; DINOPROSTONE; DRUG COMBINATIONS; EOSINOPHILS; FORSKOLIN; HISTAMINE ANTAGONISTS; HUMANS; HYPEREOSINOPHILIC SYNDROME; PROTO-ONCOGENE PROTEINS C-BCL-2; TUMOR CELLS, CULTURED;

EID: 0030403856     PISSN: 02780232     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1099-1069(199612)14:4<181::AID-HON589>3.0.CO;2-Y     Document Type: Article

References (31)

1. Weller, P. F. The immunobiology of eosinophils. N. Engl. J. Med. 1991, 324, 1110-1118.
2. Clutterbuck, E. J., Hirst, E. M. A., Sanderson, C. J. Human interleukin-5 (IL-5) regulates the production of eosinophils in human bone marrow cultures: Comparison and interaction with IL-1, IL-3, IL-6. and GMCSF. Blood 1989, 73, 1504-1512.
3. Warren, D. J., Moore, M. A. S. Synergism among interleukin-1, interleukin-3, and interleukin-5 in the production of eosinophils from primitive hemopoietic stem cells. J. Immunol. 1988, 140, 94-99.
4. Stern, M., Meagher, L., Savill, J., Haslett, C. Apoptosis in human eosinophils. J Immunol. 1992, 148, 3543-3549.
5. Matsumoto, K., Schleimer, R. P., Saito, H., Likura, Y., Bochner, B. S. Induction of apoptosis in human eosinophils by anti-Fas antibody treatment in vitro. Blood 1995, 86, 1437-1443.
6. Hockenbery, D., Nunez, G., Milliman, C., Schreiber, R. D., Korsmeyer, S. J. Bcl-2 is an inner mitochondrial membrane protein that blocks programmed cell death. Nature 1990, 348, 334-336.
7. Schena, M., Larsson, L. G., Gottardi, D., et al. Growth- and differentiation-associated expression of bcl-2 in B-chronic lymphocytic leukemia cells. Blood 1992, 79, 2981-2989.
8. Saito, H., Bourinbaiar, A., Ginsburg, M., et al. Establishment and characterization of a new human eosinophilic leukemia cell line. Blood 1985, 66, 1233-1240.
9. Morita, M., Saito, H., Honjo, T., et al. Differentiation of a human eosinophilic leukemia cell line (EoL-1) by a human T-cell leukemia cell line (HIL-3)-derived factor. Blood 1991, 77, 1766-1775.
10. Mayumi, M. EoL-1. a human eosinophilic cell line. Leuk. Lymphoma 1992, 7, 243-250.
11. Uenoyama, Y., Ohshima, Y., Morita, M., et al. Dibutyryl cyclic AMP induces formyl peptide receptor expression and chemotactic responses in a human eosinophilic cell line. EoL-1. Exp. Hematol. 1991, 19, 823-828.
12. Ohshima, Y., Nambu, M., Jung, E. Y., et al. Induction of phosphatidylinositol-linked Fcy receptor III expression on an eosinophilic cell line, EoL-1, by dibutyryl cyclic AMP and interferon-γ. Immunol. Lett. 1993, 36, 187-194.
13. Jung, E-Y., Ohshima, Y., Shintaku, N., et al. Effects of cyclic AMP on expression of LFA-1, Mac-1, and VLA-4 and eosinophilic differentiation of a human leukemia cell line, EoL-1. Eur. J. Haematol. 1994, 53, 156-162.
14. Shintaku, N., Ohshima, Y., Jung, E. Y., et al. Induction of eosinophilic granules, nonspecific esterase activity and CD14 expression in the human eosinophilic leukemia cell line, EoL-1. Hematol. Oncol. 1994, 12, 129-139.
15. Martin, S. J., Bradley, J. G., Cotter, T. G. HL-60 cells induced to differentiate towards neutrophils subsequently die via apoptosis. Clin. Exp. Immunol. 1990, 79, 448-453.
16. Nagy, L., Thomázy, V. A., Shipley, G. L., et al. Activation of retinoid x receptor induces apoptosis in HL-60 cell lines. Mol. Cell. Biol. 1995, 15, 3540-3551.
17. Rogaia, D., Grignani, F., Grignani, F., Nicoletti, I., Pelicci, P. G. The acute promyelocytic leukemia-specific PML/RARa fusion protein reduce the frequency of commitment to apoptosis upon growth factor deprivation of GM-CSF-dependent myeloid cells. Leukemia 1995, 9, 1467-1472.
18. Castaigne, S., Chomienne, C., Daniel, M. T., et al. All-trans retinoic acid as a differentiation therapy for acute promyelocytic leukemias. I. Clinical results. Blood 1990, 76, 1704-1709.
19. Yonehara, S., Ishii, A., Yonehara, M. A cell-killing monoclonal antibody (Anti-Fas) to a cell surface antigen co-downregulated with the receptor of tumor necrosis factor. J. Exp. Med. 1989, 169, 1747-1756.
20. Kayagaki, N., Kawasaki, A., Ebata, T., et al. Metalloproteinase-mediated release of human Fas ligand. J. Exp. Med. 1995, 182, 1777-1783.
21. Schmid, I., Uittenbogaart, C. H., Giorgi, J. V. A gentle fixation and permeabilization method for combined cell surface and intracellular staining with improved precision in DNA quantification. Cytometry 1991, 12, 279-285.
22. Nicoletti, I., Migliorati, G., Pagliacci, M. C., Grignani, F., Riccardi, C. A rapid and simple method for measuring thymocyte apoptosis by propidium iodide staining and flow cytometry. J. Immunol. Methods 1991, 139, 271-279.
23. Calabresse, C. Venturini, L., Ronco, G., Villa, P., Chomienne, C., Belpomme, D. Butyric acid and its monosaccharide ester induce apoptosis in the HL-60 cell line. Biochem. Biophys. Res. Commun. 1993, 195, 31-38.
24. Oltval, Z. N., Milliman, C. L., Korsmeyer, S. J. Bcl-2 heterodimerizes in vivo with a conserved homology, bax, that accelerates programmed cell death. Cell 1993, 74, 609-619.
25. L. Blood 1996, 87, 3837-3843.
26. S gene therapy induces apoptosis of human mammary tumors in nude mice. Cancer Res. 1996, 59, 1965-1969.
27. Ju, S.-T., Panka, D. J., Cui, H., et al. Fas (CD95)/FasL interactions required for programmed cell death after T-cell activation. Nature 1995, 373, 444-448.
28. Alderson, M. R., Tough, T. W., Davis-Smith T., et al. Fas ligand mediates activation-induced cell death in human T lymphocytes. J. Exp. Med. 1995, 181, 71-77.
29. McConkey, D. J., Orrenius, S., Jondal, M. Agents that elevate cAMP stimulate DNA fragmentation in thymocytes. J. Immunol. 1990, 145, 1227-1230.
30. Filippovich, I., Sorokina, N., Khanna, K. K., Lavin, M. F. Butyrate induced apoptosis in lymphoid cells preceded by transient over-expression of HSP70 mRNA. Biochem. Biophys. Res. Commun. 1994, 198, 257-265.
31. Grignani, F., Ferrucci, P. F., Testa, U., et al. The acute promyelocytic leukemia-specific PML-RARα fusion protein inhibits differentiation and promotes survival of myeloid precursor cells. Cell 1993, 74, 423-431.